Abbott to Present at Morgan Stanley Global Healthcare Conference

ABBOTT PARK, Ill., Aug. 31, 2011 /PRNewswire/ -- Abbott (NYSE: ABT) will present at the Morgan Stanley Global Healthcare Conference on Tuesday, Sept. 13, 2011. John Leonard, M.D., senior vice president, pharmaceuticals, research and development, will participate in a 30-minute discussion about the company beginning at 10:30 a.m. Central time.

A live audio webcast will be accessible through Abbott's Investor Relations Web site at  An archived edition of the presentation will be available later that day.

About Abbott

Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs nearly 90,000 people and markets its products in more than 130 countries.  

Abbott's news releases and other information are available on the company's Web site at


Suggested Articles

Despite a 45% premium offered to Allergan investors through the AbbVie buyout, one investor is suing to block the deal.

Interruptions continue to wreak havoc on the global drug supply as drugmakers respond to the detection of impurities in some commonly used meds.

Activist investor Caligan wants to rework the board of AMAG, the maker of female libido med Vyleesi, but the company isn’t giving up yet.